Meet the Current Researchers

Kevin Harrod, Ph.D.

University of Alabama at Birmingham

Novel SARS-CoV-2 antivirals targeting viral encoded ion channels

Aaron N. Hata, M.D., Ph.D.

Massachusetts General Hospital

Exploiting potent anti-viral immunity against lung cancer through antigenic reprograming

Jason Hong, M.D.

University of California, Los Angeles

Understanding Pulmonary Arterial Hypertension and Predicting Drugs at Single-cell Resolution

Terri Hough, M.D., MSc

Oregon Health & Science University

Recovery after COVID-19 Hospitalization

Lu Huang, Ph.D.

University of Arkansas for Medical Sciences

Targeting Trained Immunity to Develop Novel TB Vaccine 

Elizabeth A. Jacobsen, Ph.D.

Mayo Clinic Arizona

Why are Eosinophils Resistant to Steroid Treatment for Severe Asthma?

Dan Jane-wit, M.D., Ph.D.

Yale University

The Role of ZFYVE21 in COVID-19 Respiratory Complications

Lingtao Jin, Ph.D.

University of Florida

Targeting Protein to Overcome Immunotherapy Resistance in Small Cell Lung Cancer

Nikhil Joshi, Ph.D.

Yale University School of Medicine

Investigating the function of tumor-specific T cells in non-small cell lung

Nada Y. Kalaany, Ph.D.

Boston Children’s Hospital

Identifying metabolic alterations in lung cancer-associated cachexia

Edy Kim, M.D.

Brigham and Women’s Hospital

Seeking Targeted Treatments for Unclassifiable Lung Fibrosis

Ji Yeon Kim, Ph.D.

University of Illinois

Shedding Light on Link Between Mutations and Metabolism in Lung Cancer

Chi Li, Ph.D.

University of Louisville Research Foundation, Inc.

Inhibiting Lung Adenocarcinoma Growth by Inducing Apoptosis Independent of Bcl-2 Proteins

Bo Liang, Ph.D.

Emory University

Viral Polymerases for RSV and SARS-CoV-2 Could be Key for Prevention and Treatment

Weiwen Long, Ph.D.

Wright State University

Potential Therapeutic Target for Lung Adenocarcinoma with KRAS Mutations

Camila Lopes-Ramos, Ph.D.

Harvard University

Sex and Gender Differences in Lung Adenocarcinoma

Seyed Javad M. Moghaddam, M.D.

University of Texas M.D. Anderson Cancer Center

Developing Immuno-Prevention and Treatment Modalities for KRAS Mutant Lung Cancer

Hyung-Geun Moon, Ph.D.

University of Illinois at Chicago

CSF1-CSF1R pathway for allergen sensitization

Sharon Morley, M.D.,Ph.D.

Washington University in St. Louis

COVID-19 infection, NLRP3 inflammasome activation and therapeutic trials to treat ARDS in a mouse model

Jarrod Mousa, Ph.D.

University of Georgia

Using Monoclonal Antibodies to Protect Against Pneumococcal Pneumonia

Somashekarappa Gowda Nanjappa, Ph.D., D.V.M.

University of Illinois at Urbana-Champaign

Immunity against pulmonary fungal infections

Jac Alexander Nickoloff, Ph.D.

Colorado State University

Targeting Lethal DNA Damage to Lung Cancer Genome Alterations

Rebecca C. Obeng, M.D., Ph.D., M.P.H.

Northwestern University

Helping Immune Cells Infiltrate Lung Tumors

Andrea A. Pappalardo, M.D.

University of Illinois

How Do Schools Deal With Access to the Asthma Medication Albuterol?

Alexander Pertsemlidis, Ph.D.

University of Texas Health Sciences Center at San Antonio

MicroRNAs May Help Control Cancer Spread

Irina Petrache, M.D.

National Jewish Health

Novel risk factors for severe COVID-19 lung disease

Amanda Poholek, Ph.D.

University of Pittsburgh

Learning Protein’s Role in Allergic Asthma Could Lead to New Treatments

Kurt Prins, M.D., Ph.D.

University of Minnesota

Treating Right Heart Dysfunction to Improve Outcomes in PAH

Zhaoxia (Julia) Qu, Ph.D.

University of Southern California

Turning Myeloid Immune Cells from Pro-Tumor to Anti-Tumor in Lung Cancer

Joseph Edward Qualls, Ph.D.

Children's Hospital Medical Center

Lactate metabolism and host defense against Mycobacterium tuberculosis